\
&
Contact us
Published on | 4 years ago
Programmes Culture and society EITEIT has published the evaluation criteria for the upcoming EIT’s Call for Proposals 2021 for a new EIT Knowledge and Innovation Community (KIC) in the Cultural and Creative Sectors and Industries (CCSI).
The evaluation criteria can be found here.
The Call for Proposals will be published in October 2021 with a deadline for submissions in March 2022.
More information can be found on the EIT website.
Related news article: EIT KIC Culture & Creative Sectors and Industries - 2021 Call for Proposals
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Agro-Food, Environment Joint Research Center
The Joint Research Centre (JRC) of the Commission invites applications for hands-on training at its state-of-the-art Nanobiotechnology Laboratory. This call offers researchers the opportunity to strengthen expertise in nanomaterials, nanomedicines, advanced materials, and micro(nano)plastics, with a focus on their detection, characterisation, and i... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.